Allscripts Healthcare Solutions/ US01988P1084 /
9/28/2023 9:59:55 PM | Chg. +0.37 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
13.38USD | +2.84% | 16,527 Turnover: 220,156.84 |
-Bid Size: - | -Ask Size: - | 1.46 bill.USD | - | 12.99 |
Assets
|
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 165.6030 | 121.9130 | 88.3390 | 72.1620 | 47.9020 | ||||||
Intangible Assets | 1,049.0610 | 640.7410 | 618.0710 | 479.8040 | 408.0340 | ||||||
Long-Term Investments | 0.0000 | 37.0400 | 43.8060 | 35.8050 | 61.5530 | ||||||
Fixed Assets | 3,384.3160 | 2,322.5190 | 2,364.4770 | 1,764.3960 | 1,663.8870 | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | 567.8730 | 465.2640 | 459.7510 | 347.3550 | 327.0690 | ||||||
Cash and Cash Equivalents | 155.8390 | 174.2430 | 129.6680 | 531.1040 | 188.3510 | ||||||
Current Assets | 845.8340 | 858.9650 | 841.2620 | 1,153.2220 | 761.3420 | ||||||
Total Assets | 4,230.1500 | 3,181.4840 | 3,205.7390 | 2,917.6180 | 2,425.2290 |
Liabilities
|
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 97.5830 | 73.1660 | 104.0140 | 35.9050 | 16.8360 | ||||||
Long-term debt | 1,539.0230 | 648.3070 | 551.0040 | 167.5870 | 350.0620 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 93.6000 | 88.1000 | 21 | - | - | ||||||
Liabilities | 3,070.0780 | 1,601.0570 | 1,920.5510 | 1,251.3750 | 1,017.0910 | ||||||
Share Capital | - | - | - | - | - | ||||||
Total Equity | 1,160.0720 | 1,580.4270 | 1,285.1880 | 1,666.2430 | 1,408.1380 | ||||||
Minority Interests | 39.1900 | 29.3140 | 0.0000 | 0.0000 | - | ||||||
Total liabilities equity | 4,230.1500 | 3,181.4840 | 3,205.7390 | 2,917.6180 | 2,425.2290 |
Income Statement
|
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1,806.3420 | 1,749.9620 | 1,771.6770 | 1,502.7000 | 1,503.0370 | ||||||
Depreciation (total) | 218.5370 | 192.3460 | 207.1060 | 192.2690 | 176.1370 | ||||||
Operating Result | 41.9170 | -93.0520 | -24.4560 | -130.8800 | 77.1990 | ||||||
Interest Income | -87.4790 | -50.9140 | -43.1720 | -34.1040 | -13.1660 | ||||||
Income Before Taxes | -209.6180 | 13.1380 | -206.5160 | -149.3110 | 161.8260 | ||||||
Income Taxes | 50.7670 | -.4690 | 23.9140 | 16.6920 | -27.8510 | ||||||
Minority Interests Profit | 1.5660 | 4.5270 | .4240 | 0.0000 | 0.0000 | ||||||
Net Income | -196.4590 | 363.7400 | -182.1780 | 700.4070 | 134.4380 |
Per Share
Cash Flow
|
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 279.4150 | 67.8910 | 46.2540 | -106.7150 | -75.4280 | ||||||
Cash Flow from Investing Activities | -412.9720 | 248.0130 | -161.0560 | 1,615.1880 | -12.1750 | ||||||
Cash Flow from Financing | 198.5850 | -292.9830 | 67.3430 | -1,109.7590 | -258.8660 | ||||||
Decrease / Increase in Cash | 65.8880 | 22.2970 | -47.2560 | 399.9260 | -346.9450 | ||||||
Employees | 8,900 | 9,500 | 9,600 | - | - |